Prices on the Wall Act of 2026

119th Congress Introduced by Mariannette Miller-Meeks

The bill would require prominent price displays for prescription drugs and related products to improve pricing transparency for consumers.

Introduced in House

Overview

HR 9390, titled the Prices on the Wall Act of 2026, is a bill introduced in the 119th Congress and referred to the House Committee on Energy and Commerce. The measure has one listed co-sponsor: Representative Mariannette Miller-Meeks. As of the latest action, it has been introduced and formally referred to committee (June 23, 2026).

Purpose and intent

The bill aims to address pricing display and transparency related to prescription medications (and/or consumer pharmaceuticals) or other products by establishing requirements that would influence how prices are shown at distribution points or on product-facing materials. The exact statutory language is not provided here, but the title suggests a focus on ensuring visible price information at or near walls in certain retail or healthcare settings, potentially to curb high out-of-pocket costs, improve consumer price comparisons, or regulate pricing displays in pharmacies or clinics.

Key provisions and changes (illustrative)

Pricing display requirements: Likely mandates that sellers (such as pharmacies, retailers, or healthcare providers) display specific price information prominently where products are sold or listed, possibly near the “wall” or on wall-mounted displays, kiosks, or shelves.

Transparency standards: Could establish standards for how prices are calculated, presented (e.g., out-of-pocket cost, cash price vs. insured price), and what accompanying information must be shown (such as discounts, copays, or negotiated price terms).

Compliance and enforcement: May include penalties for noncompliance, reporting requirements, or audits to ensure adherence to pricing display rules.

Effective date and transition: The bill would specify when the requirements take effect (e.g., a future date after enactment) and whether phased implementation is allowed.

Note: The exact substantive provisions, thresholds, and regulatory mechanisms depend on the final text of the bill, which is not provided in the summary you supplied.

Who would be affected

Retailers and pharmacies: Likely required to display mandated price information in defined settings.

Healthcare providers or clinics: If prices are displayed within patient-facing areas, these entities may be subject to display requirements.

Consumers: Aim to benefit from greater price transparency, enabling easier comparison shopping and informed cost decisions.

Government and regulatory bodies: May oversee enforcement, reporting, and compliance activities.

Procedural and timeline aspects

Introduction: June 23, 2026.

Referral: Referred to the House Committee on Energy and Commerce (same day as introduction).

Legislative process: As with typical bills, advancement would depend on committee action (markup, amendments), potential floor consideration, and passage by the House, followed by possible Senate action and presidential signature or veto.

Timelines: Specific effective dates, regulatory rulemaking schedules, and transition periods would be defined in the enacted text.

Additional context

Sponsorship: Co-sponsored by Representative Mariannette Miller-Meeks, indicating support within the House.

Status: At the introductory and referral stage; no publicized committee report, amendments, or floor actions are listed in the provided history.

If you can provide the full text or a more detailed summary of HR 9390, I can refine this into a more precise and comprehensive analysis, including exact statutory provisions, definitions, penalties, and implementation dates.